The researchers found that people living in neighborhoods with the highest levels of heat vulnerability were 40% more likely ...

The accurate diagnosis of patients presenting to the emergency room with symptoms of stroke is critical; however, rapid assessment is equally important, as the benefit of thrombolytic treatment is ...

According to the World Health Organization stroke is the leading and growing cause of acquired neurological disability and second cause of death worldwide. Stroke mortality is in decline in the ...

The good news is that most women showed some improvement over time. Their scores went down slightly from three to twelve ...

Women experience worse post-stroke functional outcomes and have different recovery patterns compared to men, a new study ...

The effects of the glycoprotein IIb/IIIa receptor inhibitor tirofiban in patients with acute ischemic stroke but who have no evidence of complete occlusion of large or medium-sized vessels have not ...

A blood test conducted in a prehospital setting may rapidly distinguish between ischemic and hemorrhagic stroke, potentially facilitating more rapid, targeted treatment. The test measures the levels ...

The study analyzed data on stroke and dementia risk from 3.2 million people across the world. The link between stroke and dementia persisted even after taking into account other dementia risk factors ...

Trials have evaluated the use of clopidogrel and aspirin to prevent stroke after an ischemic stroke or transient ischemic attack (TIA). In a previous trial, ticagrelor was not better than aspirin in ...

Stroke (also called a "cerebrovascular accident," or CVA) is a disease of the blood vessels in and around the brain. It occurs when part of the brain does not receive enough blood to function normally ...

A stroke — either a blockage of blood flow to the brain or bleeding in the brain — is a medical emergency that requires immediate treatment. The two types of stroke are treated differently but can ...

Background: Thrombolysis for acute stroke is beneficial in selected patients. Because clinical trials generally exclude patients with pre-existing disability, this subgroup of patients has not been ...